Waldencast (NASDAQ:WALD - Free Report) had its price target reduced by Telsey Advisory Group from $10.00 to $8.00 in a research report report published on Wednesday, Marketbeat reports. They currently have an outperform rating on the stock.
Waldencast Price Performance
WALD traded up $0.18 on Wednesday, hitting $5.05. The company had a trading volume of 89,101 shares, compared to its average volume of 70,780. The stock has a fifty day moving average price of $6.38 and a 200-day moving average price of $8.15. Waldencast has a 12-month low of $4.71 and a 12-month high of $12.00.
Hedge Funds Weigh In On Waldencast
Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Amalgamated Bank grew its stake in shares of Waldencast by 68.1% during the third quarter. Amalgamated Bank now owns 3,277 shares of the company's stock worth $31,000 after acquiring an additional 1,328 shares during the last quarter. Barclays PLC grew its stake in shares of Waldencast by 75.3% during the third quarter. Barclays PLC now owns 7,177 shares of the company's stock worth $67,000 after acquiring an additional 3,084 shares during the last quarter. Norden Group LLC purchased a new stake in shares of Waldencast during the first quarter worth about $92,000. State Board of Administration of Florida Retirement System purchased a new stake in shares of Waldencast during the third quarter worth about $97,000. Finally, Simplicity Wealth LLC purchased a new stake in shares of Waldencast during the first quarter worth about $142,000. Hedge funds and other institutional investors own 41.97% of the company's stock.
Waldencast Company Profile
(
Get Free Report)
Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.
Featured Stories
Before you consider Waldencast, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waldencast wasn't on the list.
While Waldencast currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
